On the face of it, ADHD medications look complicated – there are a lot of them. Not only patients, but many providers have a hard time making sense of them, especially as there are new ones on the ...
Attention-deficit hyperactivity disorder (ADHD) is the most diagnosed childhood neurological disorder in Australia. To address these concerns and improve consistency in ADHD diagnosis and prescribing, ...
Young children with attention deficit/hyperactivity disorder often receive medication just after being diagnosed, which contravenes treatment guidelines endorsed by the American Academy of Pediatrics, ...
Attention-deficit/hyperactivity disorder (ADHD) is a common but complex neurodevelopmental condition characterized by symptoms of inattention, hyperactivity, and ...
The Food and Drug Administration (FDA) just approved Simtriyo (centanafadine), a new norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) and central nervous system (CNS) stimulant. The ...
Attention deficit hyperactivity disorder (ADHD) impacts the ability to maintain attention to tasks. Often, it also involves impulsive behaviour – saying or doing things without stopping to think first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results